AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: These results provides a possible mechanism linking miR-181c, PI3K/AKT pathway, drug resistance, by which altered expression of ST8SIA4 leads to drug resistance in CML cell lines.